BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 850068)

  • 1. Hypogammaglobulinemia in experimental myeloma: the role of suppressor factors from mononuclear phagocytes.
    Krakauer RS; Strober W; Waldmann TA
    J Immunol; 1977 Apr; 118(4):1385-90. PubMed ID: 850068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma.
    Waldmann TA; Broder S; Krakauer R; MacDermott RP; Durm M; Goldman C; Meade B
    Fed Proc; 1976 Jul; 35(9):2067-72. PubMed ID: 1084293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of splenectomy on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
    Havas HF; Berney S; Goodis A; Schiffman G
    Cancer Res; 1979 Sep; 39(9):3783-7. PubMed ID: 476702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression in plasmacytoma: induction of suppressor cells.
    Chen Y; Hwang LT; Heller P
    Clin Exp Immunol; 1982 Jan; 47(1):191-6. PubMed ID: 6212173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mode of action of splenic suppressor cells in murine plasmacytoma.
    Chen Y; Heller P
    Clin Exp Immunol; 1981 Sep; 45(3):514-22. PubMed ID: 6461449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression in BALB/c mice bearing the plasmacytoma TEPC-183: massive increase in red pulp macrophages induced by the tumour.
    Joshua DE; Humphrey JH; Grennan D; Brown G
    Immunology; 1980 Jun; 40(2):223-8. PubMed ID: 7409859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased T gamma and T mu cells in BALB/c mice with IgG and IgM plasmacytomas and hybridomas.
    Mathur A; Lynch RG
    J Immunol; 1986 Jan; 136(2):521-5. PubMed ID: 2934474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of an IgM plasmacytoma (TEPC-183) on the primary immune response of BALB/c mice.
    Havas HF; Schiffman G
    Immunology; 1978 Jan; 34(1):1-8. PubMed ID: 23993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
    Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells with FC receptors in myeloma; suppression of growth and secretion of MOPC-315 by T alpha cells.
    Müller S; Hoover RG
    J Immunol; 1985 Jan; 134(1):644-7. PubMed ID: 3871117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of B-lymphocyte clonal proliferation by spleen cells from plasmacytoma-bearing mice.
    Hamburger AW
    J Natl Cancer Inst; 1980 Dec; 65(6):1337-43. PubMed ID: 6968847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.
    Shanahan TC; Ceglowski WS; Havas HF
    Cancer Res; 1985 Dec; 45(12 Pt 1):6463-70. PubMed ID: 2866030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
    Patel M; Havas HF
    Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the pharmacologic manipulation of suppressor cells associated with impaired immunoglobulin production.
    Morito T; Bankhurst AD; Williams RC
    J Lab Clin Med; 1980 Aug; 96(2):232-7. PubMed ID: 6447179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogammaglobulinemia due to abnormal suppressor T-cell activity in Crohn's disease.
    Elson CO; James SP; Graeff AS; Berendson RA; Strober W
    Gastroenterology; 1984 Mar; 86(3):569-76. PubMed ID: 6229445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of T- and B-cell interactions in adult patients with combined immunodeficiency.
    Morito T; Bankhurst AD; Williams RC
    J Clin Invest; 1980 Feb; 65(2):422-31. PubMed ID: 6444306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma: an immunologic profile. Cytotoxic and suppressive effects of the EA rosette-forming cell.
    Paglieroni T; Mackenzie MR
    J Immunol; 1980 Jun; 124(6):2563-70. PubMed ID: 7373038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.